New national commission brings together leading experts to improve access to high-quality, patient-centered, evidence-based ...

オピオイド危機の社会課題解決に向けた治療薬の研究開発を推進 ASP8062の初期臨床試験に対しNIHから助成金を獲得 アステラス製薬株式会社（本社:東京、代表取締役社長CEO:安川 健司、以下「アステラス製薬」）は、オピオイド使用障害（Opioid Use Disorder: OUD ...

Nearly all Americans are aware of the U.S. opioid crisis. Overdose deaths increased sixfold between 2003 and 2023, from 12,940 to 79,358. Yearly increases have been especially steep since 2013, when ...

オピオイド使用障害（OUD）市場に関する包括的調査：業界インサイトの解明、トレンド予測、成長要因の分析、ならびに2024年～2032年の将来展望 当社の綿密な調査に基づく市場調査レポート[2024-2032]を通じて、オピオイド使用障害（OUD）市場の ...

The prevalence of use of medications for opioid use disorder increased from 2016 to 2022 among US adults undergoing surgery.

The Virginia Opioid Abatement Authority (OAA) released its 2025 Annual Report, detailing a year of historic investment, ...

A committee of the Virginia Opioid Abatement Authority approved more than half a million dollars in new grants this month, ...

In this 2025 survey study, U.S. adults viewed opioid overdose as a serious problem. Different views on the degree to which ...

People across Washington now have an easier way to get help for opioid use disorder, accordign to the Washington State ...

Approximately 88% of adults view opioid overdose deaths as a very serious problem with high agreement across political groups, according to a national survey conducted by Weill Cornell Medicine ...